The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Valbiotis Appoints Murielle Cazaubiel as Head of Development and Medical Affairs
Pharma & Human Health

Valbiotis Appoints Murielle Cazaubiel as Head of Development and Medical Affairs

OCT 10, 2018
DNAnexus-Powered Mosaic Microbiome Platform Announces Winners of Second Community Challenge
Pharma & Human Health

DNAnexus-Powered Mosaic Microbiome Platform Announces Winners of Second Community Challenge

OCT 5, 2018
Gram-negative Bacteria Increase Mortality, Vasopressor use and ICU Admission in ILD Patients
Pharma & Human Health

Gram-negative Bacteria Increase Mortality, Vasopressor use and ICU Admission in ILD Patients

OCT 5, 2018
Vedanta Biosciences Announces Successful Phase 1a/1b Data for Lead, Rationally Defined Bacterial Consortium Product Candidate
Infectious Disease & AMR

Vedanta Biosciences Announces Successful Phase 1a/1b Data for Lead, Rationally Defined Bacterial Consortium Product Candidate

OCT 4, 2018
Reading Between the Lines: What the FDA Public Workshop Really Tells Us About the Regulation of Microbiome-Based Products
Editor's Choice

Reading Between the Lines: What the FDA Public Workshop Really Tells Us About the Regulation of Microbiome-Based Products

OCT 3, 2018
Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer
Biotics and Supplements

Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer

OCT 2, 2018
Pivot Bio Closes $70 Million Series B Financing to Deliver First and Only Clean Alternative to Synthetic Nitrogen Fertilizer
Finance

Pivot Bio Closes $70 Million Series B Financing to Deliver First and Only Clean Alternative to Synthetic Nitrogen Fertilizer

OCT 2, 2018
Innovation Industries joins €18m Series A financing round of A-MANSIA
Finance

Innovation Industries joins €18m Series A financing round of A-MANSIA

OCT 1, 2018
Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer
Finance

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer

SEP 28, 2018
Research Study Demonstrates a Role for Nasal Microbiota in the Host Response to Viral Respiratory Infection
Infectious Disease & AMR

Research Study Demonstrates a Role for Nasal Microbiota in the Host Response to Viral Respiratory Infection

SEP 28, 2018
Conference Summary: Microbiome Movement Skin Health & Dermatology
Pharma & Human Health

Conference Summary: Microbiome Movement Skin Health & Dermatology

SEP 28, 2018